本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cue Biopharma, Inc.

0.2394
-0.0115-4.58%
盘后0.2200-0.0194-8.12%18:40 EDT
成交量:114.04万
成交额:26.26万
市值:2,338.00万
市盈率:-0.85
高:0.2417
开:0.2409
低:0.2224
收:0.2509
52周最高:1.05
52周最低:0.2224
股本:9,766.08万
流通股本:9,097.21万
量比:1.31
换手率:1.25%
股息:- -
股息率:- -
每股收益(TTM):-0.2808
每股收益(LYR):-0.2808
净资产收益率:-121.11%
总资产收益率:-44.56%
市净率:0.88
市盈率(LYR):-0.85

数据加载中...

2022/06/22

重要事件披露

8-K - Current report
2022/06/10

重要事件披露

8-K - Current report
2022/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/30

重要事件披露

8-K - Current report
2022/03/16

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/16

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/18

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/17

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/15

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/08

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/08

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/14

重要事件披露

8-K - Current report
2021/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/03/18

重要事件披露

8-K - Current report
2021/03/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans